Solos Endoscopy, Inc. Receives Purchase Orders from BJC HealthCare for its
MammoView(TM) Product Line
BOSTON, Oct. 27 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets:
SNDY) is pleased to announce that the Company has received purchase orders for
its MammoView(TM) line of surgical endoscopy instruments from BJC HealthCare,
St. Louis Missouri. BJC HealthCare is one of the largest nonprofit health care
organizations in the United States, delivering services to residents primarily
in the greater St. Louis, southern Illinois and mid-Missouri regions.
BJC HealthCare serves urban, suburban and rural communities and includes 13
hospitals and multiple community health locations. Services include inpatient
and outpatient care, primary care, community health and wellness, workplace
health, home health, community mental health, rehabilitation, long-term care
and hospice. Solos Endoscopy's MammoView(TM) system employs advanced micro
endoscopes and optical technology to give physicians sharp, clear images of
the milk ducts where the majority of breast cancers arise.
"We are pleased to be a supplier to one of the top health care organizations
in the United States. We believe that our MammoView line will be instrumental
in serving BJC HealthCare system hospitals' wellness initiatives," stated Bob
Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy recently announced that the Company has taken the initial
steps to get the CE Marking for its FDA approved MammoView(TM) line of
surgical instruments. This will allow the MammoView(TM) line to be sold
throughout the European Economic Union (EEU), which represents 30% or $94
Billion of the worldwide demand for medical instruments.
For more information on BJC HealthCare, please visit: www.bjc.org.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to
develop and market breakthrough technology, applications, medical devices and
procedural techniques for the screening, diagnosis, treatment and management
of medical conditions. Backed by technical support, Solos' sales team can help
make the right buying decisions for the hospital, surgery center, or physician
office with its catalog of FDA Approved products. Additional information is
available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that are not
historical facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected or suggested
herein due to certain risks and uncertainties including, without limitation,
ability to obtain financing and regulatory and shareholder approval for
anticipated actions.
SOURCE Solos Endoscopy, Inc.
Brian Neff, Investor Relations, Big Apple Consulting USA for Solos Endoscopy,
Inc. +1-407-389-5900
